BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33755994)

  • 1. N
    von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
    Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers.
    Nettersheim D; Berger D; Jostes S; Kristiansen G; Lochnit G; Schorle H
    Andrology; 2019 Jul; 7(4):498-506. PubMed ID: 30903744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGR2-mediated regulation of m
    Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
    Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
    Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
    J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Gu Y; Niu S; Wang Y; Duan L; Pan Y; Tong Z; Zhang X; Yang Z; Peng B; Wang X; Han X; Li Y; Cheng T; Liu Y; Shang L; Liu T; Yang X; Sun M; Jiang S; Zhang C; Zhang N; Ye Q; Gao S
    Cancer Res; 2021 Feb; 81(4):923-934. PubMed ID: 33293428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
    Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
    Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Chen Y; Zhou C; Sun Y; He X; Xue D
    Epigenomics; 2020 Jan; 12(2):87-99. PubMed ID: 31856595
    [No Abstract]   [Full Text] [Related]  

  • 13. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
    Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA.
    Dai X; Wang T; Gonzalez G; Wang Y
    Anal Chem; 2018 Jun; 90(11):6380-6384. PubMed ID: 29791134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDC1 mediates nuclear export of N
    Roundtree IA; Luo GZ; Zhang Z; Wang X; Zhou T; Cui Y; Sha J; Huang X; Guerrero L; Xie P; He E; Shen B; He C
    Elife; 2017 Oct; 6():. PubMed ID: 28984244
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathological and immunological characterization of RNA m
    Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
    Mizutani A; Koinuma D; Seimiya H; Miyazono K
    Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
    Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.